The stock of Symbility Solutions Inc (CVE:SY) hit a new 52-week high and has $0.74 target or 68.00% above today’s $0.44 share price. The 8 months bullish chart indicates low risk for the $107.85M company. The 1-year high was reported on Nov, 9 by Barchart.com. If the $0.74 price target is reached, the company will be worth $73.34 million more.
The 52-week high event is an important milestone for every stock because it shows very positive momentum and is time when buyers come in. During such notable technical setup, fundamental investors usually stay away and are careful shorting or selling the stock. About 122,716 shares traded hands or 123.39% up from the average. Symbility Solutions Inc (CVE:SY) has risen 6.00% since October 10, 2016 and is uptrending. It has outperformed by 1.22% the S&P500.
More news for Symbility Solutions Inc (CVE:SY) were recently published by: Marketwired.com, which released: “Symbility Expands European Footprint” on October 07, 2014. Marketwired.com‘s article titled: “Symbility Health Signs Contract With Assumption Life” and published on July 21, 2014 is yet another important article.
Symbility Solutions Inc. is a Canada technology firm focused on providing claims processing solutions for various sectors of the insurance industry. The company has a market cap of $107.85 million. The Company’s divisions include Symbility Property , which provides claims processing and estimating software for property and casualty insurers; Symbility Health (group insurance software), which provides a software that enables insurers, third-party administrators, employee benefits brokers, and the pharmaceutical industry to re-define collaboration in the healthcare system, and Symbility Strategic Services (mobile and application software), which creates and develops technologies in the area of mobile applications, the Internet of Things, machine-to-machine and wearables to different industries. It currently has negative earnings.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.